Agent Capital
Robert (Bob) Hombach is a retired CFO/COO with 27 years of financial and operational leadership experience in the biopharmaceutical & medical device sectors. Previously, Bob served as Executive Vice President, Chief Financial Officer & Chief Operations Officer for Baxalta (BXLT-NYSE), a $6B global bio-pharmaceutical company spun off from its parent, Baxter (NYSE: BAX), in 2015. Before Baxalta, Bob served as CVP & CFO for Baxter (2010 – 2015). He has an MBA from Northwestern University/Kellogg School of Management; a BS in Finance cum Laude, University of Colorado; an Elijah Watt Sells Award Winner on November 1990 CPA exam, and CMA. Recognized by IR Magazine as a Top 100 US CFO (ranked #7 in both 2013 & 2014) as voted on by institutional investors across all industries.
This person is not in the org chart
This person is not in any offices
Agent Capital
Agent Capital is a healthcare investment firm focused on novel technologies and therapeutics that address unmet patient need. Their investment areas of focus are new products and technologies for oncology, immunology, neurology and rare disease indications. They make direct equity investments across all stages of development and types of financing rounds.